Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | HRAS |
Variant | G12V |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | HRAS G12V does not lie within any known functional domains of the Hras protein (UniProt.org). G12V results in decreased Hras GTPase activity, loss of response to GTPase-activating proteins, leading to activation of downstream signaling pathways, and transformation of cultured cells (PMID: 24224811, PMID: 21850009, PMID: 6330729). |
Associated Drug Resistance | |
Category Variants Paths |
HRAS mutant HRAS act mut HRAS G12V HRAS mutant HRAS G12X HRAS G12V |
Transcript | NM_005343.4 |
gDNA | chr11:g.534288C>A |
cDNA | c.35G>T |
Protein | p.G12V |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001130442 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
NM_005343.3 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
NM_176795 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
NM_176795.5 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
NM_001130442.3 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
NM_005343 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
NM_001130442.2 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
NM_176795.4 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
NM_005343.4 | chr11:g.534288C>A | c.35G>T | p.G12V | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03190941 | Phase Ib/II | Cyclophosphamide anti-KRAS G12V mTCR cells Fludarabine Aldesleukin | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients | Recruiting | USA | 0 |